SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer

被引：0
|
作者：
Tabbo, Fabrizio [1 ]
Reale, Maria Lucia [1 ]
Ruffini, Enrico [2 ]
Novello, Silvia [1 ]
Guerrera, Francesco [2 ]
机构：
[1] Univ Torino, Dept Oncol, Turin, Italy
[2] Univ Torino, Dept Surg Sci, Turin, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 09期
关键词：
TYROSINE KINASE INHIBITORS; ERLOTINIB; PLACEBO;
D O I：
10.21037/atm.2019.03.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Epidermal Growth Factor Receptor (EGFR) mutation testing in non-small cell lung cancer (NSCLC) patients
    Eaton, Helen
    Dutton, L.
    Wallace, A. J.
    Howard, E.
    Gaunt, L.
    Blackhall, F.
    Newman, W.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 : S72 - S72
  • [22] Epidermal Growth Factor Receptor (EGFR) Mutation Testing in non-small cell lung cancer (NSCLC) patients
    Wallace, Andrew
    Howard, E.
    Dutton, L.
    Elles, R. G.
    Newman, W.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 : S66 - S66
  • [23] Complex Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Lung Cancer
    Arai, Hiromasa
    Tajiri, Michihiko
    Morita, Junya
    Kameda, Yohei
    Shiino, Kimihisa
    Okudela, Koji
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S497 - S498
  • [24] Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma
    Ahn, JH
    Kim, SW
    Hong, SM
    Suh, C
    Kim, WK
    Lee, IC
    Lee, JS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 529 - 535
  • [25] Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer
    Morinaga, Ryotaro
    Okamoto, Isamu
    Fujita, Yoshihiko
    Arao, Tokuzo
    Sekijima, Masaru
    Nishio, Kazuto
    Ito, Hiroyuki
    Fukuoka, Masahiro
    Kadota, Jun-ichi
    Nakagawa, Kazuhiko
    CANCER SCIENCE, 2008, 99 (12): : 2455 - 2460
  • [26] Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer
    McMillen, Elizabeth
    Ye, Fei
    Li, Guanghu
    Wu, Yong
    Yin, Guanghao
    Liu, Wei
    EXPERIMENTAL LUNG RESEARCH, 2010, 36 (09) : 531 - 537
  • [27] Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer Comment
    D'Avella, Christopher
    Bodor, J. Nicholas
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [28] Sublobar Resection in Early Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant
    Mimae, Takahiro
    Miyata, Yoshihiro
    Tsubokawa, Norifumi
    Shimada, Yoshihisa
    Nagashima, Takuya
    Ito, Hiroyuki
    Ikeda, Norihiko
    Okada, Morihito
    ANNALS OF THORACIC SURGERY, 2024, 118 (02): : 395 - 401
  • [29] Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib
    Clark, Gary M.
    Zborowski, Denni M.
    Culbertson, Jennifer L.
    Whitehead, Marlo
    Savoie, Michelle
    Seymour, Lesley
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 837 - 846
  • [30] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
12345